Abstract In the last decades. our understanding of the role of the immune system in cancer has significantly improved and led to the discovery of new immunotherapeutic targets and tools. which boosted the advances in cancer immunotherapy to fight a growing number of malignancies. Approved immunotherapeutic approaches are currently mainly based on immune checkpoint inhibitors. https://www.nacrack.com/